Learn More
Apexbio Technology LLC Sabutoclax 1228108-65-3 5mg

Supplier: Apexbio Technology LLC A41995
Sabutoclax (CAS 1228108-65-3) is a small-molecule inhibitor targeting multiple anti-apoptotic proteins of the Bcl-2 family including Bcl-xL Bcl-2 Mcl-1 and Bfl-1 with IC50 values of 0 31 M 0 32 M 0 20 M and 0 62 M respectively Derived from apogossypolone sabutoclax exhibits high affinity for Bcl-xL (Kd 0 11 M) and enhanced membrane permeability relative to related analogs In cellular studies sabutoclax suppresses PC3 cell proliferation (EC50 0 13 M) and induces apoptosis in human BP3 cells (IC50 0 049 M) In M2182 xenograft mouse models sabutoclax significantly reduces tumor volume with nearly complete inhibition of tumor growth at a dose of 5 mg/kg Sabutoclax is utilized to investigate Bcl-2 family inhibition in cancer research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.